Skip to main content
SpringerLink
Log in

Die randomisierte LAP07-Studie

Effekt einer Radiochemotherapie gegenüber Chemotherapie auf das Überleben von Patienten mit lokal fortgeschrittenen Pankreaskarzinomen ohne Tumorprogression nach 4‑monatiger Induktionschemotherapie mit Gemcitabin-Erlotinib

The LAP07 randomized study

Effect of chemoradiotherapy vs. chemotherapy on survival of patients with locally advanced pancreatic cancer without tumor progression after a 4‑month induction chemotherapy with gemcitabine-erlotinib

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Iacobuzio-Donahue CA, Fu B, Yachida S, Luo M, Abe H, Henderson CM et al (2009) DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 27(11):1806–1813

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P et al (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: The LAP07 randomized clinical trial. JAMA 315(17):1844–1853

    Article  CAS  PubMed  Google Scholar 

  3. Wang JP, Wu CY, Yeh YC, Shyr YM, Wu YY, Kuo CY et al (2015) Erlotinib is effective in pancreatic cancer with epidermal growth factor receptor mutations: a randomized, open-label, prospective trial. Oncotarget 6(20):18162–18173

    Article  PubMed  PubMed Central  Google Scholar 

  4. Huguet F, Andre T, Hammel P, Artru P, Balosso J, Selle F et al (2007) Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. J Clin Oncol 25(3):326–331

    Article  CAS  PubMed  Google Scholar 

  5. Mahadevan A, Miksad R, Goldstein M, Sullivan R, Bullock A, Buchbinder E et al (2011) Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer. Int J Radiat Oncol Biol Phys 81(4):615–622

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Strahlenheilkunde, Universitätsklinikum Freiburg, Albert-Ludwigs-Universität Freiburg, Robert-Koch-Str. 3, 79106, Freiburg, Deutschland

    Thomas Brunner

  2. Klinik für Strahlentherapie und Onkologie, Universitätsklinikum Frankfurt, Goethe Universität Frankfurt, Theodor-Stern-Kai 7, 60590, Frankfurt, Deutschland

    Emmanouil Fokas

Authors
  1. Thomas Brunner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanouil Fokas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas Brunner.

Ethics declarations

Interessenkonflikt

T. Brunner und E. Fokas geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brunner, T., Fokas, E. Die randomisierte LAP07-Studie. Onkologe 22, 882–885 (2016). https://doi.org/10.1007/s00761-016-0088-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-016-0088-3

Search

Navigation